疏凿饮子加减对慢性心力衰竭患者心功能、心肌重构及血清炎性因子的影响
Effects of modified Shuzao Yinzi Recipe on cardiac function, myocardial remodeling and serum inflammatory factors in patients with chronic heart failure
- 上海中医药大学学报 2021年35卷第4期 页码：18-24
- 作者机构：
1.湖北省中西医结合医院心血管内科（湖北 武汉 430015）
- 作者简介：
郭丽芬，女，硕士，副主任医师，主要从事中西医结合治疗心血管疾病临床研究
胡晓军，主任医师；E-mail：hxjsuper@163.com
- 基金信息：湖北省卫计委科研项目(WJ2017F005)
DOI：10.16306/j.1008-861x.2021.04.003
中图分类号：
扫 描 看 全 文
郭丽芬, 胡晓军, 孙玉真. 疏凿饮子加减对慢性心力衰竭患者心功能、心肌重构及血清炎性因子的影响[J]. 上海中医药大学学报, 2021,35(4):18-24.
GUO Lifen, HU Xiaojun, SUN Yuzhen. Effects of modified Shuzao Yinzi Recipe on cardiac function, myocardial remodeling and serum inflammatory factors in patients with chronic heart failure[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine, 2021,35(4):18-24.
郭丽芬, 胡晓军, 孙玉真. 疏凿饮子加减对慢性心力衰竭患者心功能、心肌重构及血清炎性因子的影响[J]. 上海中医药大学学报, 2021,35(4):18-24. DOI： 10.16306/j.1008-861x.2021.04.003.
GUO Lifen, HU Xiaojun, SUN Yuzhen. Effects of modified Shuzao Yinzi Recipe on cardiac function, myocardial remodeling and serum inflammatory factors in patients with chronic heart failure[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine, 2021,35(4):18-24. DOI： 10.16306/j.1008-861x.2021.04.003.
摘要
目的：,2,探讨疏凿饮子加减对慢性心力衰竭（CHF）患者心功能、心肌重构及血清炎性因子的影响。,方法：,2,纳入CHF患者86例，采用随机数字表将患者分为观察组与对照组，每组各43例。观察组患者给予疏凿饮子加减结合西医常规疗法治疗，对照组患者给予西医常规疗法治疗，治疗周期为4周。评价并比较两组患者的临床疗效；治疗前后，检测患者的左室射血分数（LVEF）、三尖瓣血流舒张早期最大流速与三尖瓣血流心房收缩期最大流速比值（E/A比值）、心输出量（CO），测试患者的6 min步行距离（6MWD），以评价患者的心功能；治疗前后，检测患者的血管紧张素Ⅱ（AngⅡ）、醛固酮（ALD）、脑钠肽（BNP）及超敏C反应蛋白（hs-CRP）、肿瘤坏死因子α（TNF-α）、同型半胱氨酸（Hcy）水平，以评价患者的心肌重构及炎症状态。,结果：,2,①治疗后，观察组患者的心功能改善总有效率为93.02%，对照组为81.40%，观察组的疗效优于对照组（,P,<,0.05）。②治疗后，两组患者的LVEF、CO、E/A比值及6MWD较治疗前均明显升高（,P,<,0.05，,P,<,0.01），且观察组患者的LVEF、CO、E/A比值及6MWD均明显高于对照组（,P,<,0.05，,P,<,0.01）。③治疗后，两组患者的AngⅡ、ALD、BNP水平较治疗前均明显降低（,P,<,0.01），且观察组患者的AngⅡ、ALD、BNP水平均明显低于对照组（,P,<,0.01）。④治疗后，两组患者的hs-CRP、TNF-α、Hcy水平较治疗前均明显降低（,P,<,0.05，,P,<,0.01），且观察组患者的hs-CRP、TNF-α、Hcy水平均明显低于对照组（,P,<,0.05，,P,<,0.01）。⑤随机行走模型评价结果显示，观察组患者的心功能指标、心肌重构指标及血清炎性因子的改善较对照组更显著。,结论：,2,疏凿饮子加减结合西医常规疗法可更好地改善CHF患者的心功能，降低心肌重构指标及血清炎性因子水平，值得在临床中推广。
Abstract
Objective:,2,To explore the effects of modified Shuzao Yinzi Recipe on cardiac function, myocardial remodeling and serum inflammatory factors in patients with chronic heart failure(CHF) .,Methods:,2,A total of 86 patients with CHF were included and randomly divided into the observation group and control group according to random number table, 43 cases in each group.The patients in the observation group were treated with modified Shuzao Yinzi Recipe combined with conventional western medicine, and the patients in the control group were treated with conventional western medicine.The treatment course was 4 weeks.The clinical efficacy of the two groups was evaluated and compared.Before and after treatment, the left ventricular ejection fraction(LVEF), ratio of maximum early diastolic flow velocity of tricuspid valve to maximum atrial systolic flow velocity of tricuspid valve(E/A ratio) and cardiac output(CO) were detected and 6-minute walking distance(6MWD) was measured to evaluate the cardiac function.Before and after treatment, the levels of angiotensinⅡ(AngⅡ), aldosterone(ALD), brain natriuretic peptide(BNP), hypersensitive C-reactive protein(hs-CRP), tumor necrosis factor α(TNF-α) and homocysteine(Hcy) were detected to evaluate the myocardial remodeling and inflammation status.,Results:,2,①After treatment, the total effective rate on cardiac function improvement was 93.02% in the observation group and 81.40% in the control group.The efficacy of the observation group was better than that of the control group(,P,<,0.05) .②After treatment, the LVEF, CO, E/A ratio and 6MWD in the two groups were significantly increased compared with those before treatment(,P,<,0.05,P,<,0.01), and the LVEF, CO, E/A ratio and 6MWD in the observation group were significantly higher than those in the control group(,P,<,0.05,P,<,0.01) .③After treatment, the levels of AngⅡ, ALD and BNP in the two groups were significantly decreased compared with those before treatment(,P,<,0.01), and the levels of AngⅡ, ALD and BNP in the observation group were significantly lower than those in the control group(,P,<,0.01) .④After treatment, the levels of hs-CRP, TNF-α and Hcy in the two groups were significantly decreased compared with those before treatment(,P,<,0.05,P,<,0.01), and the levels of hs-CRP, TNF-α and Hcy in the observation group were significantly lower than those in the control group(,P,<,0.05,P,<,0.01) .⑤The evaluation results of random walking model showed that the improvements of cardiac function, myocardial remodeling and serum inflammatory factors in the observation group were more significant than those in the control group.,Conclusion:,2,Modified Shuzao Yinzi Recipe combined with conventional western medicine therapy can better improve the cardiac function and reduce the myocardial remodeling indexes and serum inflammatory factors levels in patients with CHF, which is worth popularizing in clinical practice.
关键词
慢性心力衰竭疏凿饮子心功能心肌重构血清炎性因子中西医结合
Keywords
chronic heart failureShuzao Yinzi Recipecardiac functionmyocardial remodelingserum inflammatory factorintegrated traditional Chinese and western medicine
references
PEI H，MIAO W，XIE W Z，et al. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure[J]. Int Heart J，2019，60(4)：899-909.
HUANG W P，YIN W H，CHEN J S，et al. Fenofibrate Reverses Dysfunction of EPCs Caused by Chronic Heart Failure[J]. J Cardiovasc Transl Res，2020，13(2)：158-170.
HU C S，WU Q H，HU D Y，et al. Treatment of chronic heart failure in the 21st century：A new era of biomedical engineering has come[J]. Chronic Dis Transl Med，2018，5(2)：75-88.
汪斌，胡安群，刘海燕，等.血清AngⅡ、BNP及外周血中性粒细胞/淋巴细胞比值联合检测在慢性心衰患者的变化及临床价值[J].临床输血与检验，2019，21(4)：431-434.
李娜，盛柯杰，白梦蝶，等.重组人脑利钠肽治疗急性心力衰竭的疗效及对血清炎性因子的影响[J].海军医学杂志，2019，40(4)：333-335.
王莹威，刘蕾，奚玉鑫，等.疏凿饮子加减对慢性心力衰竭患者心肌重构相关因子的影响[J].中华中医药杂志，2019，34(8)：3835-3837.
高润霖，吴宁，胡大一，等.心血管病治疗指南和建议[M].北京：人民军医出版社，2004：35-36.
郑筱萸.中药新药临床研究指导原则（试行）[M].北京：中国医药科技出版社，2002：77.
朱贤慧.唐蜀华教授衷中参西辨治心力衰竭临床经验[J].南京中医药大学学报，2013，29(3)：277-279.
葛均波，徐永健.内科学[M].8版.北京：人民卫生出版社，2013：257.
解琳莉，赵勇，张为，等.从气、血、水关系探析心水之病机与治疗[J].中华中医药杂志，2012，27(8)：2113-2115.
冠心病中医临床研究联盟，中国中西医结合学会心血管疾病专业委员会，中华中医药学会心病分会，中国医师协会中西医结合医师分会心血管病学专家委员会.慢性心力衰竭中医诊疗专家共识[J].中医杂志，2014，55(14)：1258-1260.
中华人民共和国卫生部药政局.新药（西药）临床研究指导原则汇编[M].北京：中华人民共和国卫生部药政局，1993：43, 46.
杜桂琴，刘清娥.中医药治疗慢性充血性心力衰竭的研究进展[J].医学综述，2019，25(9)：1831-1834,1839.
刘宁，宋宪波，谭莉娜，等.三伏贴防治慢性心力衰竭阳气亏虚、血瘀水停证队列研究[J].中医杂志，2020，61(1)：53-57.
贺小芳，唐蓓蕾，王显，等.益气活血利水方治疗冠心病心力衰竭气虚血瘀水饮证患者疗效分析[J].现代中医临床，2020，27(3)：9-12.
MORIMOTO T，FUNAMOTO M，SUNAGAWA Y，et al. Noble Heart Failure Therapy Using Food Compositions[J]. Yakugaku Zasshi，2018，138(10)：1263-1269.
PUGLIESE N R，MASI S，TADDEI S. The renin-angiotensin-aldosterone system：a crossroad from arterial hypertension to heart failure[J]. Heart Fail Rev，2020，25(1)：31-42.
SHI L，ZHANG Y，ZHANG J，et al. Application of blood pre-albumin and NT-pro BNP levels in evaluating prognosis of elderly chronic heart failure patients[J]. Exp Ther Med，2020，20(2)：1337-1342.
黄政，方存明，程久佩，等.血清肿瘤坏死因子-α、核因子-κΒ与慢性心力衰竭病人心功能及预后的关系[J].安徽医药，2019，23(4)：672-674.
杨嘉豪，徐建虎.温阳消饮法对慢性心力衰竭模型大鼠血清血管紧张素Ⅱ、TNF-α及IL-6水平的影响[J].国际中医中药杂志，2019，41(3)：258-262.
PELLICORI P，ZHANG J，CUTHBERT J，et al. High-sensitivity C-reactive protein in chronic heart failure：patient characteristics，phenotypes，and mode of death[J]. Cardiovasc Res，2020，116(1)：91-100.
TANG J，XIE Q，MA D，et al. Effects of ET-1 and TNF-α levels on the cardiac function and prognosis in rats with chronic heart failure[J]. Eur Rev Med Pharmacol Sci，2019，23(24)：11004-11010.
吕海珍，吕云，周荣，等.血清HCY、sST2和NT-proBNP联合检测对慢性心力衰竭诊断及心功能评价的价值[J].中国实验诊断学，2019，23(6)：1002-1006.
0
浏览量
118
下载量
0
CSCD
0
CNKI被引量
- 网络PDF下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
- 总访问量：10152 今日访问量：15